GSM城市站国家站国际

俄勒冈州波特兰地区生物科技公司完成450万美元融资 以人类细胞技术替代动物试验

2026-11-12 · 科技 · GSM News
俄勒冈州波特兰地区生物科技公司完成450万美元融资 以人类细胞技术替代动物试验

总部位于俄勒冈州泰格德市的生物科技公司阿拉塞利生物科学(Araceli Biosciences)11月12日宣布,投资人杰夫·斯威卡德(Jeff Swickard)已加入该公司最近完成的450万美元融资轮。公司表示,本轮融资将支持其创纪录的商业势头:公司收入预计在2026年达到两年前的六倍。阿拉塞利开发高性能细胞成像平台,用于新药研发,其旗舰产品Endeavor平台结合超级智能(SI)分析软件,帮助研究人员观察人类细胞对候选药物的反应,更早获得更准确的数据,从而减少对动物试验的依赖。这一技术路线被称为“新方法学”(NAMs),即以人类细胞检测替代动物模型来验证药物的安全性和有效性,公司称其平台已获得全球前20大制药公司中10家的采用,业务覆盖湾区、波士顿、伦敦与柏林。斯威卡德表示,投资既是支持这家俄勒冈创新企业,也看好科学变得更智能、更快速、更人道的未来。阿拉塞利成立于2020年,2023年从Phoseon Technology分拆出来,现有员工约30人,多数在泰格德总部工作。公司称目前正进入商业化第二阶段,将推出与其平台配套的耗材产品,更大规模推广定于2027年。

Portland-Area Biotech Araceli Biosciences Closes $4.5 Million Round, Using Human-Cell Technology to Replace Animal Testing

Araceli Biosciences, a biotechnology company based in Tigard, Oregon, announced on November 12 that investor Jeff Swickard has joined its recently closed $4.5 million funding round. The company said the financing will support record commercial momentum: revenue in 2026 is expected to reach six times the level of two years ago.

Araceli develops high-performance cell-imaging platforms for new drug research. Its flagship Endeavor platform combines AI analysis software that lets researchers watch how human cells respond to drug candidates, producing earlier and more accurate data and reducing reliance on animal testing. The approach is known as New Approach Methodologies (NAMs) — using human-cell assays instead of animal models to verify drug safety and efficacy. The company says its platform has been adopted by 10 of the world's top 20 pharmaceutical companies, with business spanning the Bay Area, Boston, London and Berlin.

Swickard said the investment backs an Oregon innovator and a future in which science becomes smarter, faster and more humane. Araceli was founded in 2020 and spun out of Phoseon Technology in 2023; it has about 30 employees, most at its Tigard headquarters. The company says it is entering a second commercial phase, launching consumable products that work with its platform, with a larger rollout planned for 2027.

来源:美通社

发布:GSM·美国(发布链接)

图片来源:图:生物技术实验室(资料图)。图片来源:Wikimedia Commons,Ishtiaquebioinfo 摄,CC BY-SA 4.0。 Image: A biotechnology laboratory (file photo). Source: Wikimedia Commons, photo by Ishtiaquebioinfo, CC BY-SA 4.0.

GSM Global · 本篇英文版 English edition of this story

本市最新更多 ›

← 返回科技 全部新闻 关于我们

GSM首页白宫联邦加州南加各州社会军事司法选举世界中国城市站国家站移民宣传专题视频直播放映厅电子书电子报科技金融教育医疗影视音乐体育文旅时尚演出活动娱乐游戏生活美食户外交通汽车地产保险儿童长者留学生宠物信仰非盈利机构